Soluble Fas might serve as a diagnostic tool for gastric adenocarcinoma

BMC Cancer

Table 2 Serum levels of sFas/sFasL based on descriptive characteristics of patients with gastric adenocarcinoma

	Gastric Adenocarcinoma Group
	sFas *(pg/ml)*			sFasL *(pg/ml)*
	N*	Mean ± SE.M^†	P Value	N*	Mean ± SE.M^†	P Value
Gender
Male	41	348.89 ± 85.04	0.55	44	0.16 ± 0.06	0.28
Female	15	188.63 ± 4.54		15	0.06 ± 0.04
Economic Status
Poor	24	222.94 ± 45.98	0.93	26	0.05 ± 0.02	*0.006*
Moderate to Good	20	279.68 ± 104.11		21	0.20 ± 0.11
Educational Status
Under high school Diploma	38	262.75 ± 61.03	0.33	41	0.08 ± 0.03	*0.018*
High school Diploma & above	4	129.93 ± 35.48		4	0.60 ± 0.54
Tobacco consumption
Negative	28	234.81 ± 76.62	0.06	29	0.07 ± 0.03	0.34
Positive	15	281.3 ± 65.87		17	0.22 ± 0.13
Opium addiction
Negative	46	282.55 ± 64.73	0.37	49	0.15 ± 0.05	0.47
Positive	10	413.67 ± 202.46		10	0.10 ± 0.06
History of *H. pylori* infection ^‡
Negative	34	390.46 ± 145.66	0.64	37	0.10 ± 0.04	0.13
Positive	15	182.09 ± 21.08		15	0.14 ± 0.07

ISSN: 1471-2407